Rapid Micro Biosystems annual ebitda
2020
2021
2022
2023
2024
2025
Rapid Micro Biosystems EBITDA Growth & History (RPID)
Rapid Micro Biosystems's calculated EBITDA was −$44.1M for fiscal 2025.
View full Rapid Micro Biosystems company overviewRapid Micro Biosystems annual ebitda history
| Fiscal year | Period ended | EBITDA | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$44.1M | $2.4M | — |
| 2024 | 2024-12-31 | −$46.6M | $6.9M | — |
| 2023 | 2023-12-31 | −$53.5M | $6.9M | — |
| 2022 | 2022-12-31 | −$60.4M | −$14.7M | — |
| 2021 | 2021-12-31 | −$45.7M | −$16.7M | — |
| 2020 | 2020-12-31 | −$29.0M | — | — |
Rapid Micro Biosystems quarterly ebitda
Q2.20
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | EBITDA | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$11.6M | −$311,000 | — |
| Q1 2026 | 2026-03-31 | −$13.1M | −$2.3M | — |
| Q4 2025 | 2025-12-31 | −$11.4M | −$2.1M | — |
| Q3 2025 | 2025-09-30 | −$10.6M | $612,000 | — |
| Q2 2025 | 2025-06-30 | −$11.3M | $1.2M | — |
| Q1 2025 | 2025-03-31 | −$10.8M | $2.7M | — |
| Q4 2024 | 2024-12-31 | −$9.4M | $2.0M | — |
| Q3 2024 | 2024-09-30 | −$11.2M | $2.5M | — |
| Q2 2024 | 2024-06-30 | −$12.6M | $1.7M | — |
| Q1 2024 | 2024-03-31 | −$13.5M | $646,000 | — |
| Q4 2023 | 2023-12-31 | −$11.4M | $5.0M | — |
| Q3 2023 | 2023-09-30 | −$13.7M | $2.5M | — |
| Q2 2023 | 2023-06-30 | −$14.3M | −$892,000 | — |
| Q1 2023 | 2023-03-31 | −$14.1M | $326,000 | — |
| Q4 2022 | 2022-12-31 | −$16.4M | −$2.3M | — |
| Q3 2022 | 2022-09-30 | −$16.2M | −$4.4M | — |
| Q2 2022 | 2022-06-30 | −$13.4M | −$2.8M | — |
| Q1 2022 | 2022-03-31 | −$14.4M | −$5.1M | — |
| Q4 2021 | 2021-12-31 | −$14.1M | −$6.8M | — |
| Q3 2021 | 2021-09-30 | −$11.7M | −$6.1M | — |
| Q2 2021 | 2021-06-30 | −$10.6M | — | — |
| Q1 2021 | 2021-03-31 | −$9.3M | — | — |
| Q3 2020 | 2020-09-30 | −$7.3M | — | — |
| Q2 2020 | 2020-06-30 | −$5.6M | — | — |
Rapid Micro Biosystems ebitda trends
Over the last five reported fiscal years, Rapid Micro Biosystems's ebitda decreased from −$29.0M to −$44.1M, a change of −$15.1M. The latest reported quarter, Q2 2026, shows −$11.6M.
About the metric
What EBITDA means
EBITDA is a measure of operating performance before interest, taxes, depreciation, and amortization. It can help compare operating results, but it is not a substitute for cash flow or GAAP net income.
Calculation and source
How TickerStat calculates EBITDA
TickerStat calculates EBITDA as operating income plus reported depreciation and amortization for aligned fiscal periods. It is calculated data, not adjusted EBITDA or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Rapid Micro Biosystems filings at SEC.gov ↗